Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive

It is often said that the marketplace for new antibiotics is broken. This notion is supported by the observation that many recently-approved antibiotics to treat drug-resistant bacteria have failed commercially in a spectacular fashion. Today, companies with peak market-cap values in excess of USD 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Safir, M. Courtney, Bhavnani, Sujata M., Slover, Christine M., Ambrose, Paul G., Rubino, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400211/
https://www.ncbi.nlm.nih.gov/pubmed/32679767
http://dx.doi.org/10.3390/antibiotics9070412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400211/
https://www.ncbi.nlm.nih.gov/pubmed/32679767
http://dx.doi.org/10.3390/antibiotics9070412

Ejemplares similares